global consulting firm in the field of medical devices, IVDs, and combination products (regulatory affairs, quality management, design control, project mgmt)
Swissmedic published info regarding the CH REP: https://t.co/56Z74XgB9D
Transition periods :
class III and class IIb implantable: 31 Dec 21
class IIb (not implantable) and IIa : 31 Mar 22
class I : 31 Jul 22
Pls contact us if you require CH REP and/or PRRC services!
Innovation Council has approved #brayZ Innosuisse application with the title b-box: a stand-alone AI platform for breast cancer imaging. https://t.co/L3NzvZoY3O
This project rocks and we are thrilled to contribute!
#machinelearning#aiinhealthcare#breastcancer#digitalhealth
The Swiss Notified Body SQS published a helpful tool on their website to analyze the effect of significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD or AIMDD: https://t.co/kZY4HVf1Zy
POLITIK SCHALTET SICH BEI MEDIZINPRODUKTEN EIN
Die Schweiz kann sich bei Medizinprodukten nicht auf die unsichere und noch lange andauernde europäische MDR-Einführung verlassen.
Link zur Motion von D. Müller: https://t.co/m8dDkIiCYb
Eine Einschätzung: https://t.co/8qtQAIy8IT
Swiss Medtech Umfrage: Export in die EU mit Drittstaatanforderungen sichern. Eine lesenswerte Zusammenfassung und Interpretation von Peter Studer (Senior Advisor, confinis ag) gibt es hier: https://t.co/aRFoLv9bic
"MDR Support Panel - Combination Products"
- are you already registered? Dr. Thomas Feldmann, DQS, and Adrian Gammeter, @byConfinis, will be addressing Article 117 https://t.co/XhICkHRw45
Continuing the blog posts with regard to the implementation of the European #MDR, the article by Adam Freeman and the presentation by Frank Blömer put a focus on the requirements for audits and also shows the links to the #MDSAP program.
https://t.co/Gz6nzM9Sb7
Like a lot of things in our rapidly changing world, we’ve grown.
We are happy to announce, that @byConfinis is moving to its new office location in Sursee, the heart of Switzerland!
@byConfinis is looking for you! we want to expand our team! If you are the subject matter expert in regulatory affairs and quality management, check out your opportunities: https://t.co/i6nOL7OdK8 and
https://t.co/S2ZYTO4FOX
Some food for the brain after the festive days. Check out the blog-post by Urs Widmer, Senior Consultant at @byConfinis about GSPRs - MDR - 2017/745 - https://t.co/3n819OVqNb
What is crucial information for the Technical Documentation of your #medicaldevice regarding #compliance with the European MDR? Read the blog-post by Nicole Gabathuler, Senior Consultant at #confinis - https://t.co/kHY86hLWx4
What an exciting year 2018!
Now that we at #confinis are looking back at it, we could not afford failing to express our gratitude to you, our valued clients, partners and followers, for trusting in us.
THANK YOU!
Work in progress regarding MDR implementation - confinis and its partners - Transition periods and definitions - all clear? Check out the information provided by Ulrich Schanke and Bernd Juhre - https://t.co/7VRybZKs6m